These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18070294)

  • 1. Discarding the baby with the bathwater.
    Kowey PR; Yan GX
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1429-31. PubMed ID: 18070294
    [No Abstract]   [Full Text] [Related]  

  • 2. Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.
    Kezerashvili A; Khattak H; Barsky A; Nazari R; Fisher JD
    J Interv Card Electrophysiol; 2007 Apr; 18(3):243-6. PubMed ID: 17546486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Torsade de pointes and cardiorespiratory arrest induced by azithromycin in a patient with congenital long QT syndrome].
    Arellano-Rodrigo E; García A; Mont L; Roqué M
    Med Clin (Barc); 2001 Jun; 117(3):118-9. PubMed ID: 11459586
    [No Abstract]   [Full Text] [Related]  

  • 4. Azithromycin-induced torsade de pointes.
    Huang BH; Wu CH; Hsia CP; Yin Chen C
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1579-82. PubMed ID: 18070319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin-induced proarrhythmia and cardiovascular death.
    Howard PA
    Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsades de pointes induced by the concomitant use of ivabradine and azithromycin: an unexpected dangerous interaction.
    Cocco G; Jerie P
    Cardiovasc Toxicol; 2015 Jan; 15(1):104-6. PubMed ID: 25158669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment.
    Roden DM; Harrington RA; Poppas A; Russo AM
    J Am Coll Cardiol; 2020 May; 75(20):2623-2624. PubMed ID: 32283123
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clarithromycin-induced torsades de pointes].
    Yamaguchi S; Kaneko Y; Yamagishi T; Ohyama Y; Amano M; Arai M; Nakamura T; Hasegawa A; Kurabayashi M
    Nihon Naika Gakkai Zasshi; 2003 Jan; 92(1):143-5. PubMed ID: 12652715
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary-QT prolongation due to roxithromycin.
    Malcolm A
    Postgrad Med J; 2000 Oct; 76(900):653-4. PubMed ID: 11009582
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adverse drug reactions--case report].
    Haffner S; Lapp H; Thürmann PA
    Dtsch Med Wochenschr; 2002 May; 127(19):1021. PubMed ID: 11997869
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long QT-syndrome as a drug-induced side effect].
    Pohjola-Sintonen S
    Duodecim; 1998; 114(19):1891, 1893, 1895. PubMed ID: 11717743
    [No Abstract]   [Full Text] [Related]  

  • 12. Cisapride and fatal arrhythmia.
    Wysowski DK; Bacsanyi J
    N Engl J Med; 1996 Jul; 335(4):290-1. PubMed ID: 8657260
    [No Abstract]   [Full Text] [Related]  

  • 13. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Torsades de pointes following clarithromycin treatment.
    Gysel M; Vieweg WV; Hasnain M; Hancox JC; Kunanithy V; Baranchuk A
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1485-93. PubMed ID: 24147515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions.
    Ehrlich H; Elkbuli A
    Am J Emerg Med; 2021 Oct; 48():363-364. PubMed ID: 33551245
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long QT and torsades de pointes as adverse effects of drugs].
    Jensen K
    Ugeskr Laeger; 2000 Oct; 162(42):5654. PubMed ID: 11059311
    [No Abstract]   [Full Text] [Related]  

  • 17. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
    Johansson M; Carlsson L
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Q-T syndrome associated with oral erythromycin used in preoperative bowel preparation.
    Vogt AW; Zollo RA
    Anesth Analg; 1997 Nov; 85(5):1011-3. PubMed ID: 9356092
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs causing prolongation of QT interval and torsades de pointes.
    CMAJ; 1998 Jan; 158(1):103-4, 107-8. PubMed ID: 9475921
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic agents associated with QT interval prolongation.
    Olsen KM
    J Fam Pract; 2005 Jun; Suppl():S8-S14. PubMed ID: 15938993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.